Erik Harris, Elan
S
Hoji Alimi, Oculus Innovative Sciences
Roger Adsett, Shire
Mark Stejbach, Merck
Mike Boken, Shire
Michael Burke, Ovation
Malvinder Singh, Ranbaxy Labs
Sean McLoughlin, GlaxoSmithKline
Ludwig Hantson, Novartis
Everybody's Right
The great debate on DTC advertising is heating up again. We're going to be hearing a lot about fair balance and risk communication and costs. But what about the patients?
Jeffrey Aronin, Ovation
Vlad Hogenhuis, Merck
Safi Bahcall, Synta Pharmaceuticals
Greg Parekh, Novartis
J. Martin Jernigan, Novo Nordisk
Julie McHugh, J&J
Rich Tillyer, Merck
Jared Silverman, Cubist
John Orwin, Genentech
Tariq Arshad, Pfizer
Suzanne Delaney, AstraZeneca
Susanne Schaffert, Novartis
Evan Morris, Roche
Chris Claiborne, Millennium
Rob Perez, EVP and COO, Cubist Pharmaceuticals
John Shamsey, Bristol-Myers Squibb
Survey: Pharma Layoffs Finding Jobs
While pharma groans at the endless stream of layoffs, one headhunting firm has some encouraging news: Pharma might be cutting costs, but it's also hiring.
Google Launches Health Site
Can pharma take advantage of new healthcare data storage sites such as Google Health and Microsoft?s Health vault? Everyone?s curious, but no one?s talking.
Red Cross Gets OK to Market Emblem
American Red Cross scores a win against Johnson & Johnson in a legal battle over the use of one of the healthcare?s most recognizable symbols
Revised Prix Galien brochure
Revised Prix Galien Brochure
